151 related articles for article (PubMed ID: 36495390)
1.
Rizzo A; Racca M; Cauda S; Balma M; Dall'Armellina S; Dionisi B; Mossetti C; Bruna MC; Freddi M; Palestini N
Endocrine; 2023 May; 80(2):433-440. PubMed ID: 36495390
[TBL] [Abstract][Full Text] [Related]
2.
Gass JM; Wicke C; Mona C; Strobel K; Müller W; Metzger J; Suter-Widmer I; Henzen C; Fischli S
Endocrine; 2022 Feb; 75(2):593-600. PubMed ID: 34561784
[TBL] [Abstract][Full Text] [Related]
3.
Mathey C; Keyzer C; Blocklet D; Van Simaeys G; Trotta N; Lacroix S; Corvilain B; Goldman S; Moreno-Reyes R
J Nucl Med; 2022 May; 63(5):785-791. PubMed ID: 34413141
[TBL] [Abstract][Full Text] [Related]
4. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
[TBL] [Abstract][Full Text] [Related]
5.
Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
[TBL] [Abstract][Full Text] [Related]
6. A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies.
Michaud L; Balogova S; Burgess A; Ohnona J; Huchet V; Kerrou K; Lefèvre M; Tassart M; Montravers F; Périé S; Talbot JN
Medicine (Baltimore); 2015 Oct; 94(41):e1701. PubMed ID: 26469908
[TBL] [Abstract][Full Text] [Related]
7. The utility of 18F-fluorocholine PET/CT in the imaging of parathyroid adenomas.
Mazurek A; Dziuk M; Witkowska-Patena E; Chudzinski W; Piszczek S; Gizewska A; Saracyn M
Endokrynol Pol; 2022; 73(1):43-48. PubMed ID: 35119087
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Performance of Cervical Ultrasound,
Boudousq V; Guignard N; Gilly O; Chambert B; Mamou A; Moranne O; Zemmour M; Sharara H; Lallemant B
J Nucl Med; 2022 Jul; 63(7):1081-1086. PubMed ID: 34857659
[TBL] [Abstract][Full Text] [Related]
9. 18F-Fluorocholine PET/CT and Parathyroid 4D Computed Tomography for Primary Hyperparathyroidism: The Challenge of Reoperative Patients.
Amadou C; Bera G; Ezziane M; Chami L; Delbot T; Rouxel A; Leban M; Herve G; Menegaux F; Leenhardt L; Kas A; Trésallet C; Ghander C; Lussey-Lepoutre C
World J Surg; 2019 May; 43(5):1232-1242. PubMed ID: 30659347
[TBL] [Abstract][Full Text] [Related]
10. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of
Grimaldi S; Young J; Kamenicky P; Hartl D; Terroir M; Leboulleux S; Berdelou A; Hadoux J; Hescot S; Remy H; Baudin E; Schlumberger M; Deandreis D
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1772-1780. PubMed ID: 29680989
[TBL] [Abstract][Full Text] [Related]
11.
Cuderman A; Senica K; Rep S; Hocevar M; Kocjan T; Sever MJ; Zaletel K; Lezaic L
J Nucl Med; 2020 Apr; 61(4):577-583. PubMed ID: 31562221
[TBL] [Abstract][Full Text] [Related]
12.
Maccora D; Caldarella C; Calcagni ML
Ann Nucl Med; 2021 Apr; 35(4):469-478. PubMed ID: 33491131
[TBL] [Abstract][Full Text] [Related]
13. Performance of quantitative measurements in [
Jacquet-Francillon N; Morelec I; Germain N; Prades JM; Habouzit V; Mariat C; Bonnefoy PB; Prevot N
Front Med (Lausanne); 2022; 9():956580. PubMed ID: 35983092
[TBL] [Abstract][Full Text] [Related]
14. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging.
Uslu-Beşli L; Sonmezoglu K; Teksoz S; Akgun E; Karayel E; Pehlivanoglu H; Khosroshahi BR; Ocak M; Kabasakal L; Sager S; Bukey Y
Korean J Radiol; 2020 Feb; 21(2):236-247. PubMed ID: 31997599
[TBL] [Abstract][Full Text] [Related]
15. 18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism.
Dudoignon D; Delbot T; Cottereau AS; Dechmi A; Bienvenu M; Koumakis E; Cormier C; Gaujoux S; Groussin L; Cochand-Priollet B; Clerc J; Wartski M
Diagn Interv Imaging; 2022 May; 103(5):258-265. PubMed ID: 35039246
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism.
Araz M; Soydal Ç; Özkan E; Kir MK; İbiş E; Güllü S; Erdoğan MF; Emral R; Küçük ÖN
Nucl Med Commun; 2018 Nov; 39(11):989-994. PubMed ID: 30138157
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid imaging by (18)F-fluorocholine PET/CT in patients with primary hyperparathyroidism and inconclusive conventional methods: clinico-pathological correlations.
Zajíčková K; Zogala D; Kubinyi J
Physiol Res; 2018 Nov; 67(Suppl 3):S551-S557. PubMed ID: 30484682
[TBL] [Abstract][Full Text] [Related]
18. Dual-Time-Point
Broos WAM; Wondergem M; van der Zant FM; Knol RJJ
J Nucl Med; 2019 Nov; 60(11):1605-1610. PubMed ID: 30877179
[No Abstract] [Full Text] [Related]
19. Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT. Illustrative cases and pitfalls.
Talbot JN; Zhang-Yin J; Kerrou K; Aveline C; Vagne B; Bélissant O; Tassart M; Périé S; Bouchard P; Christin-Maitre S; Ménégaux F; Groussin L; Gaujoux S; Balogová S; Montravers F
Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):130-140. PubMed ID: 35005879
[No Abstract] [Full Text] [Related]
20.
Boccalatte LA; Gómez NL; Musumeci M; Galich AM; Collaud C; Figari MF
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):273-278. PubMed ID: 32540340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
